Skip to main content
. 2020 Feb 3;162(9):2155–2163. doi: 10.1007/s00701-020-04244-6

Table 2.

Baseline characteristics of 45 asymptomatic patients and 45 symptomatic controls treated for meningioma between 2004 and 2017

Patient and tumor characteristics Case (n = 45) Control (n = 45) p value
Female, n (%) 31 (68.9) 35 (77.8) 0.48
Karnofsky score > 70, n (%) 41 (91.1) 41 (91.1) 1.0
Predisposing factors* 5 (11.1) 1 (2.2) 0.20
Work status 0.69
  Pension, n (%) 15 (33.3) 15 (33.3)
  Sick leave, n (%) 3 (7.3) 1 (2.2)
  Partial sick leave, n (%) 3 (7.3) 1 (2.2)
  Working full hours, n (%) 19 (46.3) 24 (57.1)
  Other, n (%) 1 (2.2) 1 (2.2)
  Missing, n (%) 4 (9.8) 3 (7.3)
Main indication(s) of surgery** < 0.001
  Symptoms, n (%) 0 (0) 45 (100)
  Growth, n (%) 15 (34.9) 4 (9.3)
  Size, n (%) 10 (23.3) 16 (37.2)
  Patient’s wish, n (%) 11 (25.6) 3 (7)
  Expected natural course of disease, n (%) 4 (9.3) 2 (4.7)
  Edema, n (%) 3 (7) 2 (4.7)
  Unknown, n (%) 2 (4.7) 2 (4.7)
Preoperative embolization, n (%) 2 (4.4) 3 (6.7) 1.0
Preoperative AED, n (%) 0 (0) 16 (35.5) < 0.001
Contact or invasion of venous sinus, n (%) 16 (35.6) 20 (44.4) 0.74
Mainly left-sided tumor, n (%) 26 (57.8) 23 (51.1) 0.53
Both sides (if multiple resected at the same time), n (%) 1 (2.2) 0 (0)
Largest diameter at diagnosis in mm, mean (SD) 27.8 (12.8) 46.3 (15.3) < 0.001
Tumor volume (cm3) at diagnosis, median (Q1–Q3) 9.3 (5.3–22.2) 35.7 (15.5–61.5) < 0.001
Tumor volume (cm3) at surgery, median (Q1–Q3), n = 19 10.7 (5.7–21.2)*** N.A****
Solitary meningioma, n (%) 42 (93.3) 42 (93.3) 1.0
Edema, n (%) 18 (40.0) 30 (66.7) 0.02
Calcification, n (%) 8 (17.8) 10 (22.2) 0.79
Hyperintensity on T2, n (%) 6 (13.3) 7 (15.6) 1.0

*Brain irradiation and genetic mutations such as NF2

**May exceed 100% since several indications for surgery may co-exist

***Not all cases had several MRI before surgery

****Too few controls had follow-up MRI before surgery due to short time from diagnosis to surgery